再生元JPM2025FINALforFiling

J.P. Morgan Healthcare ConferenceJANUARY 13, 2025This non-promotional presentation contains investigational data as well as forward-looking statements; actual results may vary materially.2Strategy & Business UpdateJ.P. Morgan Healthcare Conference 2025Leonard S. Schleifer, MD, PhD Co-Founder, Board Co-Chair, President & Chief Executive Officer3Note regarding forward-looking statementsThis presentation includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risk